Dendreon Pharmaceuticals LLC FDA Inspection Record
Dendreon Pharmaceuticals LLC is an FDA-registered facility (FEI 3008914686) located in Union City, GA, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK. RegDataLab tracks 4 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Oct 29, 2025: Voluntary Action Indicated (VAI)
- Inspections on record
- 4 (4 VAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 2, latest Feb 2, 2024
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Oct 29, 2025 | Voluntary Action Indicated (VAI) | Complete test data included in records (21 CFR 211.194(a)) Control procedures to monitor and validate performance (21 CFR 211.110(a)) |
| Apr 21, 2022 | Voluntary Action Indicated (VAI) | No citations listed |
| Oct 22, 2018 | Voluntary Action Indicated (VAI) | Record review prior to release (21 CFR 606.100(c)) Corrective action documentation (21 CFR 123.7(d)) |
| Nov 1, 2016 | Voluntary Action Indicated (VAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Feb 2, 2024 | Class II | B-0312-2024 | sipuleucel-T While manufacturing Provenge infusion therapy, Dendreon noted that a single infusion drug product was manufactured using components from… |
| Dec 12, 2011 | Class III | B-0392-13 | Sipuleucel-T Provenge (sipuleucel-T), with an out-of-specification (OOS) assay result, was distributed. |
FDA record score
14 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
5 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Oct 29, 2025 | 6 x 1 | 6 |
| Inspection classified VAI | Apr 21, 2022 | 6 x 0.6 | 3.6 |
| Class II recall B-0312-2024, this FEI as the recalling firm | Feb 2, 2024 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Oct 22, 2018 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Nov 1, 2016 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Dendreon Pharmaceuticals LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Dendreon Pharmaceuticals LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Dendreon Pharmaceuticals LLC
- Location
- Union City, GA (US)
- Registration Expires
- Dec 31, 2026
- Operations
- ANALYSIS; LABEL; MANUFACTURE; PACK
- Source
- decrs